Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Molecular Oncology|February 1, 2021
Epigenetic regulator BMI1 promotes alveolar rhabdomyosarcoma proliferation and constitutes a novel therapeutic targetCara E Shields, Sindhu Potlapalli, Selma M Cuya-Smith, et al.
Biorxiv : the Preprint Server for Biology|August 8, 2025
RUNX2 inhibition disrupts a PAX3::FOXO1-RUNX2 feed-forward loop and dismantles oncogenic gene programs in fusion-positive rhabdomyosarcomaElizabeth A Mendes, Aanandi Munshi, Archana Singh, et al.
Pediatric Blood & Cancer|March 7, 2022
Clinical group and modified TNM stage for rhabdomyosarcoma: A review from the Children's Oncology GroupJacquelyn N Crane, Wei Xue, Amira Qumseya, et al.
Cell Reports|November 19, 2013
Distinct and overlapping sarcoma subtypes initiated from muscle stem and progenitor cellsJordan M Blum, Leonor Añó, Zhizhong Li, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2022
Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-StudiengruppeSimone Hettmer, Corinne M Linardic, Anna Kelsey, et al.
Cell Reports|June 15, 2017
The NOTCH1/SNAIL1/MEF2C Pathway Regulates Growth and Self-Renewal in Embryonal RhabdomyosarcomaMyron S Ignatius, Madeline N Hayes, Riadh Lobbardi, et al.
Journal of Clinical Medicine|April 30, 2021
Prioritization of Novel Agents for Patients with Rhabdomyosarcoma: A Report from the Children's Oncology Group (COG) New Agents for Rhabdomyosarcoma Task ForceHolly L Pacenta, Wendy Allen-Rhoades, David Langenau, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
CDK8 Inhibition Releases the Muscle Differentiation Block in Fusion-driven Alveolar RhabdomyosarcomaSusu Zhang, Kathleen Engel, Assil Fahs, et al.
Cold Spring Harbor Perspectives in Medicine|November 5, 2014
Rhabdomyosarcoma: current challenges and their implications for developing therapiesSimone Hettmer, Zhizhong Li, Andrew N Billin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2022
Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology GroupDavid Milewski, Hyun Jung, G Thomas Brown, et al.
Pageof 6